Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection 3 mL

Features

• HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
• HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
• HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
• HYMOVIS® is supplied in a set of 2 single-use 5 mL syringes, each containing a 3 mL dose of treatment to be injected one week apart